Similar Articles
691
Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
692
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
693
Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review
694
Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
695
Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
696
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
697
Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
698
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
699
One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation
700
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
Page 70 of 175 ( 1743 items )
<<
1
...
66
67
68
69
70
71
72
73
...
175
>>
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA